LUM and cystic fibrosis: The anti-inflammatory properties of the LUM/IVA combination were investigated by Jarosz-Griffiths et al., who highlighted a downregulation of the nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein 3 (NLRP3)-inflammasome, a key regulator of inflammation in CF.